On Demand Professional Workshop Series: Psychopharmacological Review For Clinicians Working In Adult Outpatient Settings
This presentation was originally reviewed on September 28, 2021, and broadcast live online on October 1, 2021, from 9:00 AM - 12:15 PM ET.
The views and opinions expressed by this presenter in this lecture are their own, and do not represent the views of Sheppard Pratt.
The workshop, Psychopharmacological Review for Clinicians Working in Adult Outpatient Settings will provide an overview of some of the latest advances in psychopharmacology research and changing treatment models for conditions we commonly treat in outpatient clinical settings such as anxiety disorders, unipolar and bipolar depressions with and without psychotic features.
Research over the past 5 – 10 years has lead to new understandings about mechanisms of action and the complex interactions of pharmacodynamics and pharmacokinetics that inform medication practices. How these findings have contributed to treatment practices will be discussed. For example, several new antidepressants and antipsychotic agents have hit the market in recent years which are being used alone, and in combination with the older drugs. Older TCAs, SSRIs, SNRIs and mood stabilizers are being administered according to different algorithms than they have been in the past. In addition, some of the older meds have new indications for use and are being prescribed in new ways to treat symptoms resistant to other treatments. These factors and the sometimes controversial off-label applications of medications are among the issues covered to address recent trends and practices in the treatment of mood, anxiety and psychotic conditions.
This activity is intended for psychologists, social workers, counselors, and other mental health professionals.
After this lecture, registrants will be able to:
- Identify how new research has changed our understanding of different underlying mechanisms of action particularly with regard to mood and anxiety disorders
- Identify how new research has influenced changes in medication practices.
- Identify differences in diagnostic and medication practices between unipolar depression and bipolar depression in the context of medication treatment algorithms.
- Describe the shifting perspectives about off-label use of medications.
There is no commercial support for this activity.
About the speaker
Marla M. Sanzone, PhD, MP has practiced independently in Annapolis since the early 1990s. Her clinical interests include psychopharmacology consultation, treating eating, mood and anxiety disorders, sports performance issues, and interpersonal dynamics. A previous active-duty member of the US Air Force and later, Assistant Chief of Psychology at the Baltimore Veterans Administration hospital, she developed staff training programs to assist active and retired military and their families with post-deployment integration re-acclimation. Dr. Sanzone is past president of the Maryland Psychological Association, past vice-chair of the Board of Examiners of Psychologists, and has been an active member of state and national organizations committed to equality and diversity issues, including access to care, consumer choice and prescriptive authority. She has been active in various teaching and advocacy roles, providing educational workshops for private & non-profit organizations, providing business consultation for strategic communication restructuring, and as adjunct faculty at Loyola, the University of MD School of Medicine and George Washington University.
Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she (or a partner or spouse) has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.
Marla M. Sanzone, PhD, MP reports that she has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. She will discuss off-label use of pharmaceuticals in this presentation.
Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.
Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CE activity. Sheppard Pratt designates this educational activity for a maximum of 3.0 contact hours for Psychologists.
Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 3.0 contact hours in Category II credits for Social Workers.
Counselor Statement: Sheppard Pratt has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098. Programs that do not qualify for NBCC credit are clearly identified. Sheppard Pratt is solely responsible for all aspects of the program. This activity is available for 3.0 NBCC clock hours.
- 3.00 ACEP NBCC clock hours
- 3.00 Category II credits for Social Workers
- 3.00 Psychologists
- 3.00 Participation
ON DEMAND WEBINAR: FOR BEST RESULTS WATCH USING GOOGLE CHROME
Professional Workshop Series: Psychopharmacological Review For Clinicians Working In Adult Outpatient Settings
Marla M. Sanzone, PhD, MP
Originally reviewed September 26, 2021.
Originally broadcast live October 1, 2021, from 9:00 am - 12:15 pm ET
Enduring Activity Credit Expiration Date: February 5, 2024
Activity Time: One hour recorded webinar lecture with a 15-minute evaluation process. Total Time: 1:15
TO EARN CONTINUING EDUCATION CREDIT FOR YOUR ATTENDANCE
On the OVERVIEW or REGISTER/TAKE COURSE tab, select the GREEN RECTANGLE, TAKE COURSE to begin.
The PowerPoint handout will be available for download.
After downloading the handout, select NEXT to begin and watch the video.
You may need to select play for the video to begin.
After the video follow the prompts to complete the, evaluation and attestation of credit.
Once you have completed all the components of the Course Progress bar, the certificate will be immediately downloadable.
There is no commercial support for this activity.
Questions? Look at our FAQ’s at https://cme.sheppardpratt.org/content/faq or Email email@example.com
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit